Constipation is common and does not automatically mean ileus or intestinal paralysis
Superior Weight-Loss Efficacy Versus Other GLP-1 RAs Wegovy achieved a 15.8% mean weight loss in the STEP 1 trial, whereas tirzepatide posted a 22.5% mean weight loss, prompting U.S
You shouldnt get BR+ NAD therapy if youre experiencing acute withdrawal (which usually happens within the first week of quitting a substance), if youre pregnant or breastfeeding, or if you have certain health conditions, including: a known allergy to NAD products or IV drip ingredients severe liver, kidney, or heart disease active cancer active infection G6PD deficiency For more information, talk to your healthcare provider
Allergy Asthma Immunol Res 14:674 Lee YH, Verma NK, Thanabalu T (2021) Prebiotics in atopic dermatitis prevention and management
Eternity Health Partners offers professional consultation to ensure you get the right treatment